Four Models of Telephone Support for Stimulant Recovery

November 23, 2016 updated by: University of California, Los Angeles
The overall objective of this research is to develop and refine empirically supported continuing care interventions that promote healthy behavior and sustained abstinence from illicit drug use.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

For treatment interventions to provide the desired result of long term abstinence, it is important to develop strategies to enhance the effectiveness of continued care approaches. We plan to conduct a prospective, randomized comparison of four models of counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program. Some 500 participants completing a 4-month Matrix Outpatient Model of stimulant abuse treatment will be randomly assigned to one of four counseling groups (n=100 per group): (1) unstructured/non-directive, (2) structured/non-directive, (3) unstructured/directive, or (4) structured/directive telephone counseling, or (5) a control group consisting of standard referral to Matrix aftercare, for a total sample size of 500. The two structured conditions will be based on the behavioral "prompts" identified by Farabee et al. (2002)* as being associated with drug avoidance. In the non-directive conditions, subjects will be allowed to state their own goals and how they intend to achieve them. In the directive conditions, the counselor will provide specific recommendations to help the subject adopt as many of the drug-avoidance activities as possible. Outcomes will be tracked for 12 months following completion of primary treatment (a total of 16 months after treatment admission) and will include measurement of participation in drug-avoidance activities (including aftercare participation) as well as self-reported and objective measures of substance use and related behavior change.

*Farabee, D., Rawson, R.A., & McCann, M. (2002). Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350.

Study Type

Interventional

Enrollment (Actual)

302

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Los Alamitos, California, United States, 90720
        • Twin Town Treatment Center
      • Los Angeles, California, United States, 90025
        • UCLA Integrated Substance Abuse Programs
      • Los Angeles, California, United States, 90025
        • Matrix Institute on Addictions
      • Rancho Cucamonga, California, United States, 91730
        • Matrix Institute on Addictions
      • West Hollywood, California, United States, 90069
        • Twin Town Treatment Center
      • Woodland Hills, California, United States, 91364
        • Matrix Institute on Addicitions

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males or females, 18-65 years of age.
  • Meet DSM-IV criteria (at the time of treatment admission) for cocaine or methamphetamine abuse/dependence.
  • Have completed the primary phase of treatment at a Matrix outpatient clinic.
  • Have telephone access throughout the study procedures.
  • Be able to understand and complete rating scales and to follow instructions.
  • Be willing to sign an informed consent form.

Exclusion Criteria:

  • Have participated in a treatment-related study conducted by the PI and colleagues during the previous 3 years and/or is currently enrolled in a treatment-related study.
  • Have any medical, legal, housing or transportation problem which would preclude either safe or consistent participation.
  • Have dropped out of the primary phase of treatment prior to completion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: 5
Experimental: 1
Structured Directive Telephone Support Calls
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
Experimental: 2
Structured Non-Directive Telephone Continuing Care Support
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
Experimental: 3
Unstructured Directive Telephone Support
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
Experimental: 4
Unstructured Non-Directive Telephone Support
Behavioral: Continuing Care Telephone Support
Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Urinalyses
Time Frame: At 3 months and 12 months
At 3 months and 12 months
Breathalyzer tests
Time Frame: At 3 months and 12 months
At 3 months and 12 months
Self-report of drug or alcohol use
Time Frame: At 3 months and 12 months
At 3 months and 12 months
Amount of Treatment Activities
Time Frame: At 3 months and 12 months
At 3 months and 12 months
Length of Treatment Episode
Time Frame: At 3 months and 12 months
At 3 months and 12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Addiction Severity Index (ASI)
Time Frame: At 3 months and 12 months
At 3 months and 12 months
HIV Risk-taking Behavior Scale
Time Frame: At 3 months and 12 months
At 3 months and 12 months
Concurrent Psychosocial Treatments
Time Frame: At 3 months and 12 months
At 3 months and 12 months
Drug Avoidance Activities (DAA) Survey
Time Frame: At 3 months and 12 months
At 3 months and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of California, Los Angeles

Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: David Farabee, Ph.D., UCLA Integrated Substance Abuse Programs

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2006

Primary Completion (Actual)

September 1, 2010

Study Completion (Actual)

September 1, 2011

Study Registration Dates

First Submitted

August 28, 2008

First Submitted That Met QC Criteria

August 28, 2008

First Posted (Estimate)

August 29, 2008

Study Record Updates

Last Update Posted (Estimate)

November 28, 2016

Last Update Submitted That Met QC Criteria

November 23, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01DA018208-01A1 (U.S. NIH Grant/Contract)
  • R01DA018208 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe